Douglass Winthrop Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,576
Closed -$224K 281
2021
Q3
$224K Hold
1,576
0.01% 259
2021
Q2
$246K Sell
1,576
-26
-2% -$4.21K 0.01% 249
2021
Q1
$249K Sell
1,602
-458
-22% -$70.9K 0.01% 247
2020
Q4
$308K Sell
2,060
-47
-2% -$6.64K 0.01% 225
2020
Q3
$279K Hold
2,107
0.01% 227
2020
Q2
$244K Sell
2,107
-18
-0.8% -$2.07K 0.01% 221
2020
Q1
$209K Sell
2,125
-9,585
-82% -$1.26M 0.01% 222
2019
Q4
$1.7M Hold
11,710
0.06% 96
2019
Q3
$1.56M Buy
11,710
+17
+0.1% +$2.2K 0.06% 102
2019
Q2
$1.34M Buy
11,693
+10,044
+609% +$1.18M 0.05% 105
2019
Q1
$204K Buy
+1,649
New +$187K 0.01% 233
2017
Q1
Sell
-3,992
Closed -$400K 252
2016
Q4
$400K Buy
+3,992
New +$428K 0.03% 175
2015
Q4
Sell
-4,657
Closed -$425K 245
2015
Q3
$425K Sell
4,657
-7,158
-61% -$718K 0.03% 173
2015
Q2
$1.35M Hold
11,815
0.1% 104
2015
Q1
$1.35M Buy
11,815
+8,612
+269% +$983K 0.1% 104
2014
Q4
$353K Buy
3,203
+53
+2% +$5.59K 0.03% 162
2014
Q3
$307K Buy
3,150
+67
+2% +$6.59K 0.03% 162
2014
Q2
$311K Buy
3,083
+26
+0.9% +$2.54K 0.03% 155
2014
Q1
$281K Sell
3,057
-406
-12% -$37.4K 0.03% 162
2013
Q4
$313K Buy
3,463
+515
+17% +$44.6K 0.03% 149
2013
Q3
$235K Buy
+2,948
New +$232K 0.03% 159

Other funds holding ZBH

Douglass Winthrop Advisors's ZBH Position: Q4 2021 in Review

Douglass Winthrop Advisors sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 1,576 shares — an estimated $224K sold.

Douglass Winthrop Advisors first reported a position in ZBH in Q3 2013 and held it in 21 quarters. The position peaked at $1.7M in Q4 2019. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Douglass Winthrop Advisors reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Douglass Winthrop Advisors sold 1,576 Zimmer Biomet shares in Q4 2021, an estimated $224K.
  • Douglass Winthrop Advisors first reported a position in Zimmer Biomet in Q3 2013 and held it in 21 quarters.
  • Douglass Winthrop Advisors's Zimmer Biomet position peaked at $1.7M in Q4 2019.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Douglass Winthrop Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.